Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Hemorrhage × Tranexamic Acid × Clear all

Phase

Phase 3 5 Phase 4 2 Phase NA 1 Phase 2/3 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Urologic Diseases 1 Urinary Retention 1 Urinary Bladder Neoplasms 1 Prostatic Neoplasms 1 Patient Satisfaction 1 Hemorrhage 1 Hematuria 1

Interventions

Tranexamic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06023212 2025-02-10

Tranexamic Acid Use for Bleeding Prevention in the Surgical Treatment of Metastatic Spinal Tumor in Lung Cancer Patients

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 1/2 Recruiting

Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡